111 related articles for article (PubMed ID: 21083488)
1. Connecting strategies on dried blood spots.
Abbott R; Smeraglia J; White S; Luedtke S; Brunet L; Thomas E; Globig S; Timmerman P
Bioanalysis; 2010 Nov; 2(11):1809-16. PubMed ID: 21083488
[No Abstract] [Full Text] [Related]
2. Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practices.
Evans CA; Bruce C; Emmons GT; Gallenberg L; Ji QC; Kinter LB; Musvasva E; Wickremsinhe E
Bioanalysis; 2010 Aug; 2(8):1355-9. PubMed ID: 21083334
[No Abstract] [Full Text] [Related]
3. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
Wang L; Zeng Z; Emmons G
Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
[TBL] [Abstract][Full Text] [Related]
4. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
[TBL] [Abstract][Full Text] [Related]
5. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
Spooner N
Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481
[No Abstract] [Full Text] [Related]
6. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
[TBL] [Abstract][Full Text] [Related]
7. DBS: a UK (MHRA) regulatory perspective.
Beharry M
Bioanalysis; 2010 Aug; 2(8):1363-4. PubMed ID: 21083336
[No Abstract] [Full Text] [Related]
8. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis.
Wong P; Pham R; Bruenner BA; James CA
Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483
[No Abstract] [Full Text] [Related]
9. A glowing future for dried blood spot sampling.
Spooner N
Bioanalysis; 2010 Aug; 2(8):1343-4. PubMed ID: 21083330
[No Abstract] [Full Text] [Related]
10. Assessment of DBS technology for the detection of therapeutic antibodies.
Prince PJ; Matsuda KC; Retter M; Scott G
Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
[TBL] [Abstract][Full Text] [Related]
11. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
[TBL] [Abstract][Full Text] [Related]
12. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system.
Heinig K; Wirz T; Gajate-Perez A
Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495
[TBL] [Abstract][Full Text] [Related]
13. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.
Michi M; Ferrari L
Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494
[TBL] [Abstract][Full Text] [Related]
14. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
Bowen CL; Hemberger MD; Kehler JR; Evans CA
Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
[TBL] [Abstract][Full Text] [Related]
15. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.
Lad R
Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493
[TBL] [Abstract][Full Text] [Related]
16. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors.
D'Arienzo CJ; Ji QC; Discenza L; Cornelius G; Hynes J; Cornelius L; Santella JB; Olah T
Bioanalysis; 2010 Aug; 2(8):1415-22. PubMed ID: 21083342
[TBL] [Abstract][Full Text] [Related]
17. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates.
Denniff P; Spooner N
Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489
[TBL] [Abstract][Full Text] [Related]
18. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
Liang X; Jiang H; Chen X
Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
[TBL] [Abstract][Full Text] [Related]
19. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
[TBL] [Abstract][Full Text] [Related]
20. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
Kehler JR; Bowen CL; Boram SL; Evans CA
Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
